A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
It will stay mostly dry with clear spells tonight. However, we may see a few showers around western coasts by dawn.
The announcement comes as part of efforts to tackle air pollution.
The Shadow Chancellor, John McDonnell, says tariff free access to the single market is their objective.